Expression of sphingosine kinase 1 in breast cancer and its clinical significance
Xiaodong Zheng,Yan Zhang,Huiying Fang,Minghao Wang,Yi Zhang,Jun Jiang
DOI: https://doi.org/10.3877/cma.j.issn.1674-0807.2015.02.005
2015-01-01
Abstract:Objective To investigate the expression of sphingosine kinase 1 ( Sphk1 ) and its correlation with clinicopathological characteristics and with E-cadherin expression in breast cancer. Methods We collected 171 cases of breast tissue specimens resected in Department of Breast Surgery, Chongqing Cancer Institute from September 2003 to May 2006, including 20 cases of breast fibroadenoma and 151 cases of invasive ductal carcinoma. Immunohistochemistry was used to detect Sphk1 and E-cadherin expression in all breast tissue specimens. The correlations of Sphk1 expression with clinicopathological characteristics and E-cadherin expression were analyzed. The count data were processed usingχ2 test, rank data using rank sum test. Results Sphk1 was positive in 114 cases of breast cancer (75. 50%,114/151), negative in all 20 cases of breast fibroadenoma;the difference was significant (χ2=45. 298,P=0. 000); Sphk1 expression was significantly associated with lymph node metastasis(Z=-6. 122,P=0. 000), ER (χ2=4. 478,P=0. 034)and HER-2 expression(χ2=7. 313,P=0. 013), not correlated with the patient’ age(χ2 =2. 791,P=0. 095), menopausal status(χ2 =0. 010, P=0. 919), tumor diameter (Z=-0. 249, P=0. 804)or PR expression(χ2=0. 740,P=0. 390). In all patients with invasive ductal carcinoma, the patients with different E-cadherin and Sphk1 expression status showed a significant difference in lymph node metastasis (χ2= 17. 187, P=0. 001). The positive rate of lymph node metastasis was 85. 71%(18/21) in the patients with E-cadherin (-) and Sphk1 (+) , 30. 77% (8/26) in the patients with E-cadherin (+) and Sphk1 (-), indicating a significant difference (χ2= 14. 189, P<0. 008). Conclusion Sphk1 may play an important role in the development and metastasis of breast cancer, which can be a useful indicator to predict the biological behaviors of breast cancer.